Silo Pharma (SILO) Long-Term Debt Issuances (2012 - 2021)
Silo Pharma (SILO) posted Long-Term Debt Issuances of $2366.0 for Q1 2021, down 96.62% sequentially from $70000.0 in Q4 2020, and down 84.23% YoY from $15000.0 in Q1 2020.
Silo Pharma (SILO) Long-Term Debt Issuances (2012 - 2021) Analysis & Trends
Silo Pharma has reported Long-Term Debt Issuances for 3 years, with the latest figure at $2366.0 in Q1 2021.
- Quarterly Long-Term Debt Issuances fell 84.23% year-over-year to $2366.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $2366.0 (down 93.24% YoY) and the FY2021 annual result came in at $2366.0, down 93.24% from the prior year.
- Long-Term Debt Issuances retreated to $2366.0 in Q1 2021 per SILO's latest filing, from $70000.0 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $70000.0 in Q4 2020 and troughed at -$53900.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2,366.00 |
| Mar 31, 2021 | 2,366.00 |
| Dec 31, 2020 | 70,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Sep 30, 2020 | -53,900.00 |
| Sep 30, 2020 | -53,900.00 |
| Jun 30, 2020 | 3,900.00 |
| Jun 30, 2020 | 3,900.00 |
| Mar 31, 2020 | 15,000.00 |
| Mar 31, 2020 | 15,000.00 |
| Dec 31, 2012 | 5,000.00 |
| Dec 31, 2012 | 5,000.00 |
| Mar 31, 2012 | 15,000.00 |
| Mar 31, 2012 | 15,000.00 |